FDA is only one of 4 regulators and Dr Ashkan holds HUGE sway in the UK. Derisked. Big pharma link Merck was vetted and approved to get a close look. Derisked. AF is going to be so full of and covered with grapefruit juice he won’t have time to say anything when he gets the chance to come up for air. Derisked. OTC can’t do much to hurt good news from a partnership or buyout. Derisked. The etc, etc. are the ducks that Linda will put in her soup if they don’t fall into line. Derisked. The bumpy ride always happens at lift off but the direction is up. Lol. Best wishes.
Red-Hot Biotechs to Take Spotlight at Blood Disorder Meeting (ASH)
Quick summaries on roughly 16 drugs with results to be shared ASH over the next few days (including times of presentations). Companies mentioned include Crispr, Trillium, Fate, Allogene, Regeneron, Bluebird, Forma, IGM Biosciences, Uniquire, Legend, Constellation, Gilead, Amgen, JNJ, Syndax, Seagen, Takada, Incyte,
News 
Market Data 
Discover 
